Saúde
Com nova e revolucionária tecnologia constantemente a desafiar o status quo, o setor da saúde está a evoluir. Mas num setor baseado em regulamentações, parcerias estratégicas são por vezes a chave para desenvolver negócios de forma bem sucedida. Os nossos assessores, apoiados por equipas sub-sectoriais globais, utilizam o seu conhecimento em M&A, growth equity e ECM, debt advisory e serviços de corporate finance, para encontrar a sua vantagem competitiva, gerir hábitos locais e ajudá-lo a criar a melhor estratégia.
Contactar acessor
Laboratório S. José foi adquirido pela SYNLAB
Os acionistas privados do Laboratório S. José venderam a empresa à SYNLAB.
Saber maismove UP has been acquired by Acture B.V.
move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.
Saber maisKKR to invest in Precipart Group Ltd.
Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.
Saber mais
Jan-Frederik Kolthoff
Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH
/var/www/html/web/app/themes/oaklins/functions.php on line 89{"deal_id":"109552","click_category":"deals","title":null,"tile_category":"quote"}" >Ler mais

Businesses are shaping the future through M&A
QUARTERLY M&A ACTIVITY: In 2024's Q4, Oaklins completed 90 M&A transactions, with TMT and Healthcare leading, reflecting innovation and strategic growth.
Saber mais
Fale com os nossos assessores locais
Conheça os nossos especialistas setoriais globais
Michael S. Goldman
Oaklins TM Capital